Related references
Note: Only part of the references are listed.Partially latent class models for case-control studies of childhood pneumonia aetiology
Zhenke Wu et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2016)
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
Donna P. Ankerst et al.
EUROPEAN UROLOGY (2015)
Subtyping: What It Is and Its Role in Precision Medicine
Suchi Saria et al.
IEEE INTELLIGENT SYSTEMS (2015)
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer
Jeffrey J. Tosoian et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Smarter Screening for Cancer Possibilities and Challenges of Personalization
Sameer D. Saini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Modeling grade progression in an active surveillance study
Lurdes Y. T. Inoue et al.
STATISTICS IN MEDICINE (2014)
Development and Multi-Institutional Validation of an Upgrading Risk Tool for Gleason 6 Prostate Cancer
Matthew Truong et al.
CANCER (2013)
An exploration of the missing data mechanism in an Internet based smoking cessation trial
Dan Jackson et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
Marc A. Dall'Era et al.
EUROPEAN UROLOGY (2012)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance
Sima P. Porten et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Assessing the Performance of Prediction Models A Framework for Traditional and Novel Measures
Ewout W. Steyerberg et al.
EPIDEMIOLOGY (2010)
Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach
Cecile Proust-Lima et al.
BIOSTATISTICS (2009)
Integrative Predictive Model of Coronary Artery Calcification in Atherosclerosis
Michael McGeachie et al.
CIRCULATION (2009)
Personalized cancer therapy gets closer
Erika Check Hayden
NATURE (2009)
Modeling disease progression with longitudinal markers
Lurdes Y. T. Inoue et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2008)
Domain-Level Covariance Analysis for Multilevel Survey Data With Structured Nonresponse
A. James O'Malley et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2008)
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker
MS Pepe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Latent class models for joint analysis of longitudinal biomarker and event process data: Application to longitudinal prostate-specific antigen readings and prostate cancer
HQ Lin et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
Share Paper
